News

Mechanism of melanoma formation elucidated

05-01-2012

Collaboration between NKI-AVL AstraZeneca and Agendia wins Best Partnership Alliance Award

11-24-2011

This three-way collaboration between a major research-based pharmaceutical company, a innovative molecular diagnostics company, and a leading national cancer institute won the award Best Partnership Alliance Award 2011.

NKI withdraws two scientific publications

10-15-2010

The Netherlands Cancer Institute (NKI) has asked the editorial staff of two scientific journals to withdraw two of its publications. Both articles describe fundamental research on the mechanism of metastasis, carried out by one of NKI’s PhD students.

Appointment Professor Reuven Agami

04-08-2009

Reuven Agami has been appointed as professor of MicroRNA and pathogenesis. In his work he identifies and characterizes genes involved in the molecular pathology of cancer and DNA-damage signalling pathways in humans.

Biomarker associated with poor outcome in aggressive childhood cancer

04-07-2009

Results from a new study identify a biomarker that may be useful for predicting the outcome of treatment for neuroblastoma, the most common cancer in young children.

Impact blood-brain barrier in brain tumor chemotherapy

04-03-2009

Nienke de Vries her thesis identified a number of components that impede transport of chemotherapeutic drugs to the brains.

coorperating oncogenes

04-01-2009

On Thursday April 9th 2009, Panthea Taghavi will defend her thesis titled “From LPA signaling to Polycomb; oncogenic cooperations revealed by genetic screens and dynamics and recruitment of polycomb group proteins”.

Two million euros to fight lung cancer

01-20-2009

Prof. Dr. Ton Berns received KWO fund of two million euros.

Vici grant for chromosome organisation

01-14-2009

Dr. Bas van Steensel receives 1.25 million euros to investigate chromosome organisation.

Mirjam Epping receives Rubicon

01-13-2009

Grant for investigation of which genes play a role in the development of prostate cancer

Appointment Professor John Haanen

10-07-2008

He has been appointed as professor of Translational Immunotherapy of Cancer at Leiden University on behalf of the Association of the Netherlands Cancer Insitute, effective October 1.

Thesis Nuno Rocha

10-02-2008

In his thesis he describeds the molecular mechanisms governing intracellular transport of MHC class II compartments or MIICs.

Appointment Professor Daniel Peeper

10-02-2008

Dr. Daniel Peeper has been appointed as professor of Functional Oncogenomics at the VU university medical center (VUmc) Amsterdam, effective October 1.

Thesis defence Annelies Jorritsma

08-28-2008

In her thesis Annelies Jorritsma discusses different immunotherapeutic strategies that can be used for the treatment of cancer.

European Comprehensive Cancer Center Alliance (ECCCA)

08-26-2008

Three leading European Comprehensive Cancer Centres launch an international cooperation at top level.

Ton Schumacher receives grant

08-21-2008

The American Melanoma Research Alliance gives Ton Schumacher a grant for his outstanding research on treatment of melanoma.

Vidi-grants for Elisabetta Citterio and Karin de Visser

08-12-2008

Last week two young, talented NKI-AVL researchers received a Vidi-grant from the Netherlands Organisation for Scientific Research (NWO).

Genetic profiling breast cancer

07-03-2008

Treatment of breast cancer with chemotherapy prior to surgery to reduce the tumor size has a better outcome when the genetic profile is known.

How inflammatory proteins can protect against cancer

06-13-2008

Thesis Anna Keller

05-16-2008

Anna Keller will defend her thesis titled “The role of CD 70/CD27 interactions at the dendritic cell/T cell interface”.

Thesis Anja Duursma

05-16-2008

Two stories with common themes

Discovery of several hundreds of potential cancer genes

05-16-2008

Researchers have found over 250 new genes that are potentially involved in the development of leukemia.